Evaluación de Ropinirol frente a Apomorfina para la inducción de la Emesis en perros
Evaluación de Ropinirol frente a Apomorfina para la inducción de la Emesis en perros
Resumen
Objetivo: Comparar la eficacia de las gotas oftálmicas de ropinirol (ROP) y la apomorfina (APO) intravenosa para inducir la emesis en perros en un contexto de urgencias y comparar los efectos adversos de ambos fármacos.
Diseño: Ensayo clínico prospectivo, aleatorizado, realizado entre octubre de 2021 y marzo de 2023.
Entorno: Dos centros privados de referencia de especialidades. 45
Evaluación de Ropinirol frente a Apomorfina para la inducción de la Emesis en perros
Introducción
Animales: Ciento treinta y dos perros de clientes con ingestión confirmada
o sospechada de material extraño.
Descargar aquí
Evaluación de Ropinirol frente a Apomorfina para la inducción de la Emesis en perrosMás información
Contribuciones del autor
Brandi L. Mattison: conceptualización, administración del proyecto, supervisión, redacción del borrador original, redacción, revisión y edición. Deborah A. Keys: depuración de datos, análisis formal, software, redacción del borrador original. Tereza Stastny: conceptualización, curación de datos, análisis formal, investigación, metodología, administración del proyecto, recursos, supervisión, validación, visualización, redacción del borrador original, redacción, revisión y edición.
Conflictos de intereses
Los autores declaran no tener ningún conflicto de intereses.
Notas finales
a Clevor, Orion Corporation, Espoo, Finlandia.
b SAS versión 9.4, SAS Institute Inc., Cary, NC.
Bibliografía
1. J. A. Lee, “Emergency Management and Treatment of the Poisoned Small Animal Patient,” Veterinary Clinics of North America: Small Animal
2. N. A. Rosenstein, J. A. Johnson, and K. S. Kirchofer, “Ropinirole Has Similar Efficacy to Apomorphine for Induction of Emesis and Removal of Foreign and Toxic Gastric Material in Dogs,” Journal of the American Veterinary Medical Association 26, no. 8 (2023): 1140–1146.
3. V. Beasley, “Diagnosis and Management of Toxicoses,” in Veterinary Toxicology, 5th ed., ed. V. Beasley (International Veterinary Information Service, 1999), accessed September 3, 2022, https://www.ivis.org/library/veterinary-toxicology.
4. N. Bates, P. Rawson-Harris, and N. Edwards, “Common Questions in Veterinary Toxicology,” Journal of Small Animal Practice 56, no. 1 (2015): 298–306.
5. W. F. Young and H. G. Bivins, “Evaluation of Gastric Emptying Using Radionuclides: Gastric Lavage Versus Ipecac-Induced Emesis,” Annals of Emergency Medicine 22, no. 9 (1993): 1423–1427.
6. C. Elwood, P. Devauchelle, J. Elliott, et al., “Emesis in Dogs: A Review,” Journal of Small Animal Practice 51, no. 1 (2010): 4–22.
7. M. Suokko, L. Saloranta, T. Lamminen, T. Laine, and J. Elliott, “Ropinirole Eye Drops Induce Vomiting Effectively in Dogs: A Randomised, Double-Blind, Placebo-Controlled Clinical Study,” The Veterinary Record 186, no. 9 (2020): 283.
8. S. Ribarič, “The Pharmacological Properties and Therapeutic Use of Apomorphine,” Molecules 17, no. 5 (2012): 5289–5309.
9. L. Belkacemi and N. A. Darmani, “Dopamine Receptors in Emesis: Molecular Mechanisms and Potential Therapeutic Function,” Pharmacological Research 161 (2020): 105124.
10. R. Scherkl, A. Hashem, and H. H. Frey, “Apomorphine-Induced Emesis in the Dog-Routes of Administration, Efficacy and Synergism by Naloxone,” Journal of Veterinary Pharmacology and Therapeutics 13, no. 2 (1990): 154–158.
11. K. S. Kirchofer, G. Block, and J. A. Johnson, “Efficacy of Intravenous Administration of Apomorphine for Removal of Gastric Foreign Material in Dogs: 495 Cases (2010-2015),” Journal of the American Veterinary Medical Association 255, no. 4 (2019): 459–465.
12. S. A. Khan, M. K. McLean, M. Slater, S. Hansen, and S. Zawistowski, “Effectiveness and Adverse Effects of the Use of Apomorphine and 3% Hydrogen Peroxide Solution to Induce Emesis in Dogs,” Journal of the American Veterinary Medical Association 241, no. 9 (2012): 1179–1184.
13. J. P. Blancquaert, R. A. Lefebvre, and J. L. Willems, “Emetic and Antiemetic Effects of Opioids in the Dog,” European Journal of Pharmacology 128, no. 3 (1986 Sep 9): 143–150.
14. D. C Plumb, “Apomorphine HCl,” in Plumb’s Veterinary Drug Handbook, 9th ed., ed. D. C. Plumb (JohnWiley & Sons, 2018), 86–87.
15. C. Szymanski, S. Boey, and J. S. Hermida, “Ropinirole-Induced Symptomatic Sinus Node Dysfunction,” Pacing and Clinical Electrophysiology 31, no. 8 (2008): 1079–1082.
16. C.M.Kaye and B. Nicholls, “Clinical Pharmacokinetics of Ropinirole,” Clinical Pharmacokinetics 39, no. 4 (2000): 243–254.
17. C. Fischer, K. J. Drobatz, and V. J. Thawley, “Evaluation of Subcutaneous Versus Intravenous Administration of Apomorphine for Induction of Emesis in Dogs,” Journal of the American Veterinary Medical Association 259, no. 3 (2021): 283–287.
18. M. R. Nystrom, A. Odunayo, and C. C. Okafor, “Assessment of Hydromorphone and Dexmedetomidine for Emesis Induction in Cats,” Journal ofVeterinaryEmergency and Critical Care 29, no. 4 (2019): 360–365.
19. T. Giordano, P. V. M. Steagall, T. H. Ferreira, et al., “Postoperative Analgesic Effects of Intravenous, Intramuscular, Subcutaneous or Oral Transmucosal Buprenorphine Administered to Cats Undergoing Ovariohysterectomy,”Veterinary Anaesthesia and Analgesia 37, no. 4 (2010): 357–366.
20. D. D. Cote, D. M. Collins, and F. J. Burczynski, “Safety and Efficacy of an Ocular Insert for Apomorphine-Induced Emesis in Dogs,” American Journal of Veterinary Research 69, no. 10 (2008): 1360–1365.
21. K. M. Zersen, N. Peterson, and P. J. Bergman, “Retrospective Evaluation of the Induction of Emesis With Apomorphine as Treatment for Gastric Foreign Bodies in Dogs (2010-2014): 61 Cases,” Journal of Veterinary Emergency and Critical Care 30, no. 2 (2020): 209–212.
22. T. E. Eurell and R. E. Peacock, “Induction of Emesis With Apomorphine Using a Novel Gingival Administration Method in Dogs,” Journal of Veterinary Emergency and Critical Care 31, no. 6 (2021): 795–799. 23. J. E. Swagzdis, R. W. Wittendorf, R. M. DeMarinis, and B. A. Mico, “Pharmacokinetics of Dopamine-2 Agonists in Rats and Dogs,” Journal of Pharmaceutical Sciences 75, no. 10 (1986): 925–928.
24. B. A. Mico, J. E. Swagzdis, D. A. Federowicz, and K. Straub, “Functional GroupMetabolism of Dopamine-2 Agonists: Conversion of 4-(2-Din- Propylaminoethyl)-2-(3H)-Indolone to 4-(2-Di-n-Propylaminoethyl)-7- Hydroxy-2-(3H)-Indolone,” Journal of Pharmaceutical Sciences 75, no. 10 (1986): 929–933.
25. S. J. Humphrey, C. N. Turman, J. T. Curry, and G. J. Wheeler, “Cardiovascular and Electrocardiographic Effects of the Dopamine Receptor Agonists Ropinirole, Apomorphine, and PNU-142774E in Conscious Beagle Dogs,” Journal of Cardiovascular Pharmacology 47, no. 3 (2006): 337–347.
26. J. Simkó, N. Szentandrássy, G. Harmati, et al., “Effects of Ropinirole on Action Potential Characteristics and the Underlying Ion Currents in Canine Ventricular Myocytes,” Naunyn-Schmiedebergs Archives of Pharmacology 382, no. 3 (2010): 213–220.
Date de alta y recibe nuestro 👉🏼 Diario Digital AXÓN INFORMAVET ONE HEALTH
Date de alta y recibe nuestro 👉🏼 Boletín Digital de Foro Agro Ganadero
Noticias animales de compañía
Noticias animales de producción
Trabajos técnicos animales de producción
Trabajos técnicos animales de compañía